Work

Abstract 1910: GDC-4198, a next-generation CDK4/2 inhibitor, induces durable cell cycle arrest and shows combination benefit with giredestrant.

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-1910

Authors: Marc Hafner, Steffan Vartanian, Luca Gerosa, Nont Kosaisawe, Michael S. Hwang, Eva Lin, Yi-Chang Wang, Jason Oeh, Tianyi Chen, Kazi N. Islam, Alice Zheng, Karen Samy, Udi Segal, John G. Moffat, DANIEL ZINGG, Annie Collier, Ioannis Sanidas, Zhi Xie, Seth A. Wander

Institutions: Genentech, Massachusetts General Hospital

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148829470

Cites:

Cited by:

Related to: